AI assistant
Sending…
Krystal Biotech, Inc. — Director's Dealing 2021
Jan 5, 2021
31006_dirs_2021-01-05_c4e80d5c-15f3-491b-bbc0-e2f140b19b5d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Krystal Biotech, Inc. (KRYS)
CIK: 0001711279
Period of Report: 2021-01-04
Reporting Person: Marantz Jing L. (Director)
More from Krystal Biotech, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 4
Interim / Quarterly Report
2026
May 4
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4